Literature DB >> 18489856

ENHANCE and ACCORD: controversy over surrogate end points.

Steven E Nissen1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18489856     DOI: 10.1007/s11886-008-0027-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  4 in total

1.  Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.

Authors:  Stephan Fichtlscherer; Caroline Schmidt-Lucke; Susanne Bojunga; Lothar Rössig; Christopher Heeschen; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2006-04-18       Impact factor: 29.983

2.  Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans.

Authors:  Ulf Landmesser; Ferdinand Bahlmann; Maja Mueller; Stephan Spiekermann; Nina Kirchhoff; Svenja Schulz; Costantina Manes; Dieter Fischer; Kirsten de Groot; Danilo Fliser; Günter Fauler; Winfried März; Helmut Drexler
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

3.  Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.

Authors:  John J P Kastelein; Philip T Sager; Eric de Groot; Enrico Veltri
Journal:  Am Heart J       Date:  2005-02       Impact factor: 4.749

4.  Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia.

Authors:  Claude Gagné; Harold E Bays; Stuart R Weiss; Pedro Mata; Katherine Quinto; Michael Melino; Meehyung Cho; Thomas A Musliner; Barry Gumbiner
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

  4 in total
  2 in total

1.  Opposing Gatekeepers of Apical Sterol Transport: Niemann-Pick C1-Like 1 (NPC1L1) and ATP-Binding Cassette Transporters G5 and G8 (ABCG5/ABCG8).

Authors:  J Mark Brown; Liqing Yu
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2009-03

2.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.